278 Dementia Japan Vol. 32 No. 3 September F BC : F : F : F :
|
|
|
- めぐの やなぎしま
- 5 years ago
- Views:
Transcription
1 F : F : Peter J. Whitehouse Transdisciplinary Professor, Case Western Reserve University and University of Toronto F : George Perry Dean and Professor, Semmes Foundation Distinguished University Chair in Neurobiology College of Sciences, The University of Texas at San Antonio, San Antonio, TX F A :
2 278 Dementia Japan Vol. 32 No. 3 September F BC : F : F : F : F A : 24
3 F BC : F : F : F : F A : Tsuneya Ikezu Boston University School of Medicine, Boston, Massachusetts, United States 25
4 280 Dementia Japan Vol. 32 No. 3 September F BC : F : F : F : F : 26
5 F : F : F : F : F : 27
6 282 Dementia Japan Vol. 32 No. 3 September F : F : F : F : F : 28
7 F : F : F : F :
8 284 Dementia Japan Vol. 32 No. 3 September F A : ips / 1. ; 2. in vitro trial ips microrna F BC : BPSD β F : 1. Aβ 2. Aβ p3 - Alcβ 30
9 β 4. Aβ KLK7 5. Aβ F : BPSD 3. BPSD 4. BPSD AI Nursing F :
10 286 Dementia Japan Vol. 32 No. 3 September F : F A : 1. Glymphatic system MRI α F BC : 1. : 2. Risk and protective factors for dementia in a community : the Hisayama Study 32
11 β F : 1. Factors Important to the Development of New Alzheimer s Disease Therapies Biogen Inc. Samantha Budd Haeberlein 2. First step toward disease modification in AD - targeting beta amyloid and tau proteinopathies Global Head of Neurodegeneration and AD Franchise Head PD Neuroscience F. Hoffmann - La Roche Ltd. Rachelle S. Doody 3. BACE1 Inhibitor CNP520 in the Alzheimer Prevention Initiative API Generation Program Global Program Head, Neuroscience, Novartis Pharma AG Ana Graf 4. The role of amyloid and tau PET imaging in therapeutic clinical trials for Alzheimer s Disease Vice President of Imaging, Avid Radiopharmaceuticals a wholly owned subsidiary of Eli Lilly Michael D. Devous 5. Clinical Development for Early Alzheimer s Disease Based on the Amyloid Hypothesis Neurology Business Group, Eisai Inc., Wood Cliff Lake, NJ, USA Johan Luthman 6. Clinical Studies in Asymptomatic Subjects at High Risk for Alzheimer s Disease AD Janssen Research and Development, Fremont, California, USA John Thipphawong F : / 1. / 2. TMG 3. 33
12 288 Dementia Japan Vol. 32 No. 3 September F : F : Aβ APOE and TREM2 as key microglial molecules for neurodegenerative phenotypes in Alzheimer s disease Boston University School of Medicine, Boston, Massachusetts, United States Tsuneya Ikezu F A : 1. 34
13 D 4. NPO F BC : NTT 1. ICT NTT Cognitive Assessment for Dementia, ipad version 2 CADi F : 1. :
14 290 Dementia Japan Vol. 32 No. 3 September F : : 3. : F : Cnm Streptococcus mutans F A : 1. progress pitfall : MRI 2. SPECT 36
15 MIBG 4. DAT F BC : 1. : F : 1. WPI - IIIS
16 292 Dementia Japan Vol. 32 No. 3 September F A : F BC : F : 1. DNA 2. TDP
17 RNA 4. RNA RAN F : F A : 1. Primary age - related tauopathy PART 2. Argyrophilic grain disease 3. Cerebral age - related TDP - 43 pathology and arteriolosclerosis CARTS 4. SNAP PET 39
18 294 Dementia Japan Vol. 32 No. 3 September F BC : 1. DLB 2. DLB 3. DLB pitfall 4. DLB F : mrna F :
19 F : 1. treatable dementia : F : 1. REST : KEAP1 - NRF2 41
20 296 Dementia Japan Vol. 32 No. 3 September F : 1. TDP Aβ : 20 15:20 1F : : F : : : AD ADL BPSD Cognitive function AD ABC AD 42
21 F A : : : PMDA GLP, non - GLP GMP STR STR F BC : / : : 1 kg 1-1.5% 1 neurovascular unit, NVU NVU small vessel disease F Sponsor : Chugai Pharmaceutical Co., Ltd. : Hiroyuki Arai Institute of Development, Aging and Cancer, Tohoku University : Rachelle Doody Global Head of Neurodegeneration, F.Hoffmann - La Roche Ltd. One of the greatest areas of unmet need remaining in medicine is the need for disease modifying drugs for congenital and chronic neurological diseases. At Roche, we are targeting Multiple Sclerosis ; Neurodegenerative disorders, including Alzheimer s disease, Parkinson s disease, Huntington s disease, and Amyotrophic Lateral Sclerosis ; Neuromuscular diseases, especially Spinal Muscular Atrophy ; and the Neurodevelopmental disorder, Autism. Our approach to each disease is driven by the extent of our scientific understanding of these diseases, and our belief that the intervention is potentially transformational. In MS, we believe that treatments targeting B Cells are able to affect all forms of the disease, both relapsing remitting and chronic progressive. For Alzheimer s and Parkinson s disease, we target the proteinopathies of these diseases with monoclonal antibodies. For the rapidly progressive disorder, ALS, we target the pathway involved with cell death. For the genetic disorders of SMA and HD, we utilize gene modifying therapies, and our approach to Autism is based upon the neuroendocrine targets known to be associated with social behaviour. The ultimate goal is to provide lasting and impactful therapies for these disorders. 43
22 298 Dementia Japan Vol. 32 No. 3 September F : : 1. : 2. : / TEA F : / : : Aβ Aβ MCI J - ADNI Aβ F : : : 44
23 F : / : : Alzheimer AD MCI AD A N T AD - MCI A - N+ SNAP suspected non - AD pathophysiology - MCI AD AD F A : : : BPSD BPSD BPSD BPSD AMED BPSD F BC : : : AD 45
24 300 Dementia Japan Vol. 32 No. 3 September F : : : Alzheimer s disease : AD disease - modifying drug : DMT β Aβ DMT Semagacestat β solanezumab 3 AD DMT F : EPD : : QOL F : : : BPSD 46
25 F : IQVIA : : β β F : : : AD AD NMDA AD AD F A : : : 47
26 302 Dementia Japan Vol. 32 No. 3 September F BC : : : DLBPD PD 7 25 mg DLB DLB F : RI : : 6 DLB Cinglate Island Sign CIS EBM F : : : 48
27 F : : : frailty F A : MSD : : F : : : 49
28 304 Dementia Japan Vol. 32 No. 3 September F : : : AD BM AD Aβ42 t - p - BM BM AD BM F Sponsor : Eli Lilly Japan K.K. : Michael D. Devous Vice President, Avid Radiopharmaceuticals, Inc F A : : / : : DLB DaT - SPECT 50
29 F : : : Alzheimer Alzheimer F : / : : AD DLB VaD FTLD DLB DLB DLB DLB F : : : MS MS MS MS 51
30 306 Dementia Japan Vol. 32 No. 3 September β 002 APP Aβ Kallikrein - related peptidase CA1 005 The analysis of APP βctf - mediated vesicle traffic impairment PET 18F PM - PBB3 010 FUS AT N system 013 β : 014IMR 015IMR 016 AD continuum THK
31 Logopenic PET 018 Nationwide survey on cerebral amyloid angiopathy in Japan Department of Neurology and Neurobiology of Aging, Kanazawa University Kenji Sakai 019 β 020 Proximity Ligation Assay Aβ β Aβ : 022 β β O - Force 025 β Catalytide O - Force 026 APPswe/PS1dE9 027 In vitro β 028 seed Aβ 029 β 030 β 031 Expression of APP770 in normal and Alzheimer s disease brains 032 γ 033 Iron - treatment enhances γ - secretase activity and inhibits amyloid depostion 034 β - amyloid precursor protein APP processing 53
32 308 Dementia Japan Vol. 32 No. 3 September γ p3 Alcβ - AD 036 Glycosylation deficiency of nicastrin induces cleavage defect of γ - secretase 037 p3 - Alcβ37 p3 - Alcβ Aβ42 oligomer p3 Alcβ PKA PKC Aβ : 042 CD14 and Toll - like receptor 4 promote fibrillar Aβ uptake by microglia through clathrin - mediated pathway Department of Neurology, School of Medicine, Sapporo Medical University Fujikura Mai 043 :Aβ 044 PSEN1 045 : α FKBP12 - immunopositive inclusions in patients with α - synucleinopathies 050 WPI - IIIS 051 α 54
33 X11L ApoE4 053 apolipoprotein E Aβ dynamics 054 Regulation of expression and release of ApoE in cultured astrocytes 055 ApoE ips 056 Effect of lactoferrin on ApoE secretion from cultured astrocytes Nagoya City University Medical Sciences Biochemistry Jung CG 057 APOE2 promotes longevity ; a clinical and preclinical assessment 058 Apolipoprotein E 059 APOE 060 APOE APP : 061 2N3R Tau C DPAA Tau 066 Rho - ROCK
34 310 Dementia Japan Vol. 32 No. 3 September Aβ ILEI/FAM3C 072 Aβ ILEI TREM APP Alcadein α 077 Phosphorylation of Alcadeinα is required for kinesin - 1 association Laboratory of Neuroscience, Graduate School of Pharmaceutical Sciences, Hokkaido University Anqi Hu 078 RNA 079 Precision Medicine 080 CJD - V180I C9 - ALS/FTD 083 Rubicon 084 APP NL - G - F 085 AD 086 A new generation of human - close Alzheimer s disease rat model AgenT
35 VS 089 Analysis of phospholipid species in AD model mouse brain by LC - MS/MS Haque MD MSC transplant decreases Aβ and increases angiogenesis in Aβ - infused rats Sheikh Abdullah Fibril - inoculated alpha - Synuclein BAC Tg mice 098 α 099 Tau protein induced neural impairment in tauopathy mice : tau PET and H - MRS study 100 mglur5 PET rtg Silencing of FUS in the marmoset caudate induces disruption of fiber tracts Effect of TRF on memory, proteome profile, and amyloid pathology in APP/PS1 mice Hamezah Hamizah Shahirah Bifidobacterium breve A1 106 Shiga - Y5 Aβ 57
36 312 Dementia Japan Vol. 32 No. 3 September Alcadeinβ p3 Alcβ - Aβ NMDA 109 β 110 α 111 Nose - to - Brain New therapy of Alzheimer s disease and schizophrenia based on D - cell hypothesis Dept Psychiatry, Iwaki Kyoritsu Gen Hosp Ikemoto Keiko β C 120 Characterization of the selective binding properties of crenezumab Genentech, Inc., a member of the Roche Group William Meilandt 121 Identification of alprenolol as an anti - prion compound using SPRi 122 B ApoE E4 C : 124 MCI 58
37 US - ADNI 126 β 127 Immuno Magnetic Reduction AD, MCI Aβ42 Tau 128 Cerebrospinal fluid and blood biomarkers in neurological diseases 129 Aβ 130 p - Tau PSEN1 Zhu Bin RNA 136 AD mirna DNA 140 Alzheimer tauopathy extended CENSUS 59
38 314 Dementia Japan Vol. 32 No. 3 September JBBN : α IMP - SPECT Cingulate Island Sign 150 AD DLB ECD - SPECT CIS core 151 IMP - SPECT CIScore DLB AD 152 Scenium 123I - FP - CIT SPECT DAT - SPECT parkinsonism SPECT 158 JCHO 60
39 HDLS 160 CSF1R 161 AARS2 162 MRI Gerstmann - Sträussler - Scheinker GSS Common neurologic and psychiatric symptoms as initial manifestations of CJD 166 E200K Creutzfeldt - Jakob disease 167 V180I 168 MM1 MM2 scjd MRI 169 MM2 Creutzfeldt - Jakob 170 MRI 171 Creutzfeldt - Jakob 172 Sporadic CJD with codon 129 valine homozygosity and cerebellar peduncle lesions :
40 316 Dementia Japan Vol. 32 No. 3 September : 178 : bapwv MRI HDL 185 : Cognitive Function Instrument CFI 62
41 Mild cognitive impairment tau 203 Lewy Lewy 3 204/ PET 205 Dementia praecox An 84 - year - old female case of mixed dementia complicated with NPH Yuki Asahara MELAS 63
42 318 Dementia Japan Vol. 32 No. 3 September MRI Deep Learning 214 SPECT 215 The effect of aging on the CBF by 123I - IMP SPECT in normal subjects and AD 216 SPECT cingulate island sign F - PM - PBB3 PET F - AV45 PET amnestic MCI AD 220 AD continuum THK THK5351 PET 222 PiB - PET 223 PiB PET SUVR PADRE PiB Incretin s Neuroprotective Effect 64
43 ; Aβ Alzheimer 236 Aβ : Aβ 237 Aβ Aβ 238 Safety and pharmacokinetics of crenezumab in Mild - to - Moderate AD patients Genentech, Inc. Helen Lin 239 Phase I Clinical Study of Crenezumab in Japanese Patients with AD 240 Logopenic progressive aphasia Chinese letter 242 Pisa syndrome induced by switching donepezil to galantamine
44 320 Dementia Japan Vol. 32 No. 3 September preclinical AD / JCHO 251 ABC 252 MMSE 253 FCSRT MR 254 DLB 255 DLB : mg 258 Noise Pareidolia Test Pure Autonomic Failure with Lewy bodies
45 REM sleep without atonia : VOSP 266 GDS β FAB 272 3T MRI CHADS2 R2CHADS MCI
46 322 Dementia Japan Vol. 32 No. 3 September Yokukansan for BPSD : Meta - Analysis of Randomized Controlled Trials 280 & NTT : MCI Safety and Tolerability of Gantenerumab High - dose Open Label Extension Study F. Hoffmann - La Roche Ltd Danielle Abi - Saab 298 Amyloid Pet Results of Gantenerumab High - dose Open Label Extension Studies Roche Pharma Research and Early Development Gregory Klein 68
47 BPSD 303 ADHD 304 ADL IADL 308 DBD BPSD Q 311 BPSD HDS - R MOCA - J MCI 314 Cognitive Performance of the User experience - Trail Making Test UX - TMT MCI 69
48 324 Dementia Japan Vol. 32 No. 3 September MMSE MoCA - J MCI AD AD - ADL MCI MMSE 324 MRI default mode net work 325 NMR 326 AD DLB 327 MCI ECD - SPECT MRI & 70
49 ; 338 Wernicke 99mTc - ECD SPECT 339 Alzheimer 340 ; 341 ; 342 : face to face 71
50 326 Dementia Japan Vol. 32 No. 3 September , MSW EA :
51 BPSD ADL CDR DASC DASC - 21 AD MCI 73
52 328 Dementia Japan Vol. 32 No. 3 September : 390 DBD DBD : 393 ADL MSW
53
untitled
239 10 3 14 00 14 50 1 : 10 2 10 30 11 30 1 : 10 4 13 00 14 00 1 : 10 2 13 00 14 00 1 : Peter St. George - Hyslop University of Toronto 10 2 14 10 15 10 1 : Randall Bateman Neurology at Washington University
プログラム_指定演題.indd
400 Dementia Japan Vol. 27 No. 4 October 2013 11 9 13 45 14 15 1 : 11 9 14 15 15 15 1 : β β Jorge A Ghiso Departments of Pathology and Psychiatry, New York University School of Medicine, New York, USA
56: Hands-on 4 Meet the Expert.
56:136 57 2016 28 5 18 21. 650-0046 6-9-1 650-0046 6-11-1 650-0046 6 10-1 2016 2 9 7 13 Hands-on 4 Meet the Expert. http://www.neurology-jp.org/sokaitiho/neuro2016/ 15,000 18,000 3,000 3,000 3,000 3,000
Diagnosis of Dementia: Update
10 C A 1 2 Normal SMI MCI Early Dementia B Moderate Dementia 3 Severe Dementia 4 5 D AD, VD, FTD, DLB, PDD Depression Dementia d/t GMC Modifiable risk factors and preventive factors for dementia 6-5 -
) 5 Lawton QOL 4 4 QOL Lawton 4) Philadelphia Geriatric Center Affect Rating ScaleARS ARS QOL 5) HDS R
Vol. 12 No. 2 2002 389 397 Λ1 Λ2 16 10 30 1 2 Lawton Philadelphia Geriatric Center Affect Rating ScaleARS Lawton ARS + ARS 6 2 ARS 2 12:00 15:0017:00 11:30 16:00 1 2 ARS 1 2 ARS QOL QOL QOL 1) QOL QOL
<93C195CA D834F E696E6464>
45 I I Diabetes and Heart: Insight by Imaging Juhani Knuuti Turku PET Centre, Turku University Central Hospital II I Development and Application of Beta-Amyloid Imaging Agents Chet A. Mathis Department
16,,, 38, (1990) 17 J Toxicol Sci, 15 (Suppl IV), (1990) 18 Cognitive enhancers ( ), 13, (1990) ,, 120, (1991) 20,
1974 1,, 25, 1385-1391 (1974) 1983 2,, 34, 1451-1454 (1983) 1984 3,, Phencyclidine (PCP),, 4, 133-147 (1984) 1985 4,,,, 11, 132-146 (1985) 1986 5 Phencyclidine Angel Dust, 138, 178-180 (1986) 6, 6, 660-666
Special IssueDiagnoses and therapeutic agents for age-related diseases Reviews Original Case reports β Medicinal drugs affecting on clinical laboratory blood test results and adverse effects of them
PET n = 7 AD n = 20 図 3 PiB AD A 3. わが国のアミロイド PET の現状 PET 100 PiB 15 BF 図 4 J-ADI 105 図 5 20%MCI 60% AD 90% MCI AD AD E ApoE 4 AD 4 図 6 4.
病態理解と薬剤開発におけるアミロイド PET 検査の現状 Current Status of Amyloid PET in Pathophysiological Research and Drug Development for Alzheimer s Disease 東京都健康長寿医療センター研究所附属診療所 / 所長 * 1. はじめに PET A A AD 図 1 AD AD PET 2. アミロイド
第６１巻５・６号（１２月号）／特集１頁目（本刷）
Special Issue 1Sudden cardiac death symposium in Tokushima Special Issue 2How to do for your health? Reviews Original Epidemiologic problems of sudden death of school children in Tokushima Prefecture
Vol.0 No. 0 図 Montreal Cognitive AssessmentMoCA orientation visuospatial attention orientation 4 visuospatial executive MMSE MoCA language language me
Parkinson 病の認知機能障害を MMSE と MoCA により評価した多施設共同研究 : 慶應 PD データベース Cognitive impairment in Parkinson s disease patients evaluated by the Montreal Cognitive Assessment and the Mini-Mental State Examination.
総 説 6 6 PIMs P S J 7
2018 10 1-6 総 説 2018 P S J 1 2018 10 7-13 総 説 6 6 PIMs P S J 7 2018 10 19-29 誌上シンポジウム JASDS DSM 1997 2012 15 DSM DSSP JASDS DSM DSSP P S J 19 2018 10 30-34 誌上シンポジウム ADME 30 Pharmacy Society of Japan 2018
118 Dementia Japan Vol. 31 No. 1 January 2017 表 1. DLB に対して mect を行った先行研究 Rasmussen K 2003 USA Japan Japan Japan Japan 1 2
Dementia Japan 31 : 117-124, 2017 117 症例報告 要旨 1. はじめに 70 1 modified electroconvulsive therapy ; mect mect Modified electroconvulsive therapy in dementia with Lewy bodies with drug - resistant psychiatric
Medical Journal of Aizawa Hospital Medical Journal of Aizawa Hospital Vol. 10 (2012) Key words ö γ µ Graves disease and Hashimoto s thyroiditis are autoimmune thyroid diseases. Graves disease causes
untitled
1) :. : 2008,,, pp734, 2008 2) :. : 2008,,, pp748, 2008 3) : (. RLS. 1.,, 2008 4) :. RLS). 1.,, pp42, 2008 5) : 100 Q&A..,, pp259-266, 2008, : 6 (5. ).,, pp99-105, 2008 1) Miyaoka T, Yasukawa R, Yasuda
9 : 00 11 : 00 12 : 00 12 : 10 12 : 50 13 : 30 14 : 40 16 : 00 17 : 00
9 : 00 11 : 00 12 : 00 12 : 10 12 : 50 13 : 30 14 : 40 16 : 00 17 : 00 ポスターについて 1. ポスター 貼 付 用 の 展 示 ボードは 縦 180 横 90cm の 大 きさです 2. 演 題 名 発 表 者 名 所 属 を 明 記 したもの(20 70cm) をご 用 意 ください 実 際 使 用 できるスペースは 155
flF™m…−…n„Efic’æ’¶
44 2006 Cognitive Rehabilitation by means of Personal Computer for Cerebrovascular Disease Patients with Attentional Disorders 1 1 2 2 5 4 1 PC ABA design 4 PASATTMT Ponsford PC SAS working memoryattention
Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST
Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST 13) Danaeus, A., Johansson, S. G. O., Foucard, T. & Ohman, S.: Clinical and immunogical aspects of food allergy in childhood.
2 10 The Bulletin of Meiji University of Integrative Medicine 1,2 II 1 Web PubMed elbow pain baseball elbow little leaguer s elbow acupun
10 1-14 2014 1 2 3 4 2 1 2 3 4 Web PubMed elbow pain baseball elbow little leaguer s elbow acupuncture electric acupuncture 2003 2012 10 39 32 Web PubMed Key words growth stage elbow pain baseball elbow
606 Dementia Japan Vol. 29 No. 4 October 2015 Table 1. The day care for people with severe dementia Outline Subjects Personal distribution Medical man
Dementia Japan 29 : 605-614, 2015 605 原著 要旨 1. はじめに 1 26 4.2 80 2 3 A survey of daycare facilities for dementia people in Japan Tohmi Osaki, Kiyoshi Maeda 1 650-0017 7-5 - 2 Medical Center for Dementia,
Soundcell Method（SCM）による高齢者の認知機能評価の可能性
Soundcell Method SCM Soundcell Soundcell Method SCM Soundcell Soundcell SCM SCM SCM SCM MMSE TMT-A TMT-BSCM SCM SCM SCM MMSE MMSE SCM SCM Soundcell Soundcell Method Soundcell Soundcell Soundcell Soundcell
untitled
The 42 nd Annual Meeting of Japan Brain Science society 42 2015 111213 42 1. 2. 3. 4. 5. 1. 2. 3. 4. 10 http://www.anahirmiyazaki.com/ 10 269 220 ANA 2 2 1000 1016 930 946 1110 1126 1040 1056 1340 1356
1 6 1 3 1 4 4 6 11 13 30 14 10 1 6 11 14 10 15 00 1 6 12 13 10 14 00 1 A novel psychotherapeutic intervention for treatment resistant depression and suicidal behaviour at the Life Promotion Clinic: Emotion
平成１４年度 本態性多種化学物質過敏状態の調査研究 研究報告書
226 227 µ 228 Ω 229 230 0 ppb 2000ppb DG subthreshold (µa) 91 ± 59 86 ± 68 max stim. (µa) 755 ± 287 n=37 678 ± 300 max PS (mv) 8.7 ± 3.9 7.7 ± 4.3 n=61 CA1 subthreshold (µa) 36 ± 26 32 ± 13 max stim. (µa)
23 7 24 3 49 237 24 3 (1) 23 7 7 (2) 4 23 1) European Fedaration of Neurological Societies, Sep 10-13, 2011Budapest, Hungary the 1 st Korea-Japan NeuroRehabilitation Coference, March 17, 2012, Seoul, Korea
pp 427 438 2006 Dimensional Change Card Sort ****** ** 2005 9 30 2004 8 2002 4 Zelazo, P. D., Carter, A., Reznick, J. S. & Frye, D. 1997 10 2003 Zelaz
Title 幼 児 の 実 行 機 能 の 発 達 過 程 : Dimensional Change C を 用 いたルールの 理 解 とその 使 用 に 関 する 検 討 Author(s) 浮 穴, 寿 香 ; 橋 本, 創 一 ; 出 口, 利 定 Citation 東 京 学 芸 大 学 紀 要. 総 合 教 育 科 学 系, 57: 427-438 Issue Date 2006-02-00
Core Ethics Vol.
Core Ethics Vol. Core Ethics Vol. . % % % Core Ethics Vol. %, Core Ethics Vol. % % % -. %. Core Ethics Vol. a b : Core Ethics Vol. pp... pp.. pp... pp. pp.. pp...pp.... pp. pp. pp.. pp.. Vol.. pp... pp..
NL16-1_0329
No.16-1 March. 2012 JAMTTC News Letter http://jamttc.umin.jp/ Japanese Association for Molecular Target Therapy of Cancer 135-85503-8-31 TEL: 03-3520-0111 ext.5413 FAX: 03-3570-0484 ...1 JAMTTC2012...2...3...4...5
1 4 1 13 1 4 6 7 2012 7 27 12 50 13 40 1 7 27 13 40 14 30 1 7 28 13 20 14 10 1 Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode Charles L. Bowden
Vol. 36, Special Issue, S 3 S 18 (2015) PK Phase I Introduction to Pharmacokinetic Analysis Focus on Phase I Study 1 2 Kazuro Ikawa 1 and Jun Tanaka 2
Vol. 36, Special Issue, S 3 S 18 (2015) PK Phase I Introduction to Pharmacokinetic Analysis Focus on Phase I Study 1 2 Kazuro Ikawa 1 and Jun Tanaka 2 1 2 1 Department of Clinical Pharmacotherapy, Hiroshima
CHEMOTHERAPY APR. 1984
VOL.32 S-3 CHEMOTHERAPY dihydro-4-oxo-7-(1-piperazinyl)-1, 8-naphthyridine- CHEMOTHERAPY APR. 1984 VOL.32 S-3 CHEMOTHERAPY Table 1 Implantation rates and post- implantation survival rates in females mated
8 The Bulletin of Meiji University of Integrative Medicine API II 61 ASO X 11 7 X-4 6 X m 5 X-2 4 X 3 9 X 11 7 API 0.84 ASO X 1 1 MR-angio
7-14 2010 1 1 1 2 1 1 1 2 Fontaine II ASO61 3 API ASO ASO ASO API API KKKKKKKKKK ASO Fontaine II API Received April 14, 2009; Accepted July 16, 2009 I arteriosclerosis obliterans: ASO ASO 50 70 1,2 Fontaine
untitled
5 K 5 3 HP http://www.mhlw.go.jp/bunya/shakaihosho/iryouseido01/taikou03.html 2004 1 2 1 http://www.dm-net.co.jp/calendar/2007/06/005835.php 6 85cm 100cm 2 90cm 2 TG 150mg/dl HDLHDL-C 40mg/dl 130mmHg 85mmHg
24回日本エイズ学会誌1_ indd
10 ICAAP 11 24 9:40 10:10 1 B1F 1. 10 Myung-Hwan Cho 2. Zahid Hussein President of AIDS Society of Asia and the Pacific ASAP 11 24 13:10 15:40 1 B1F 1 13:10 13:55 PS1-1 ART in the Developing World: Progress
Microsoft Word - プログラム（タイトル）.docx
8:55-9:00 9:00-10:15 O1 O5 9:00 O1 1 1 2 1 1 2 9:15 O2 HDAC 1 1 1 1 2 3 9:30 O3 1 1 1 1 2 3 9:45 O4 inos/nox 1)2) 1) 1) 1. 2. 10:00 O5 GAD67-GFP knockin CRH GABA 1,2 2 3 4 2 1 2 3 4 10:15-10:25 10:25-11:25
05_藤田先生_責
This report shows innovation of competency of our faculty of social welfare. The aim of evaluation competency is improvement in the Social welfare education effects, by understanding of studentʼs development
スライド 1
1 2006 msv 2 2011 3 CT 2011 10mSv 10 40mSv 4 2012 217mSv 5 (CT) 2012 50 60mSv 6 2012 510mSv BRCA25 310 10mSv3% BRCA60-280% 3 5m Sv 1m Sv 12% . http://www.rea.or.jp/ire/pdf/report4.pdf 1.10 20 SMR 1.00
Vol.21 No AD Japanese-ADNI J-ADNI 2015 AMED AD NA-ADNI 400 AD AD 2. NA-ADNI 研究の主な成果 NA-ADNI 2004 NA-ADNI ADNI, ADNI-GO ADNI-2 phase
アルツハイマー型認知症のバイオマーカーの現状と課題 Biochemical biomarkers for Alzheimer s disease: present status and awaiting solution 京都府立医科大学分子脳病態解析学 / 教授 * 1. はじめに 460 65 10 1 85 3 1 Alzheimer s disease AD 5 7 2500 AD 460
596 Dementia Japan 29 : , 2015 原著 1,2 1,2 1,3 1,4 1,4 1,5 1,5 1,6 1,7 1,8 要 旨 Activity of Initial - phase Intensive Support Team for Dementia o
596 Dementia Japan 29 : 596-604, 2015 原著 1,2 1,2 1,3 1,4 1,4 1,5 1,5 1,6 1,7 1,8 要 旨 Activity of Initial - phase Intensive Support Team for Dementia of Kobe City Hiroyuki Kajita 1,2, Kiyoshi Maeda 1,2,
Special IssueOncology Nutrition Reviews Proceeding DNA β Nutrition and physical activity and the prevention of cancer Yutaka Taketani Department of Clinical Nutrition, Institute of Health Biosciences,
Juntendo Medical Journal
* Department of Health Science Health Sociology Section, Juntendo University School of Health and Sports Science, Chiba, Japan (WHO: Ottawa Charter for Health promotion, 1986.) (WHO: Bangkok Charter
The nursing practices nurses consider important in the tertiary emergency rooms Kanako Honda'', Chizuko Miyake'', Midori Yao", Mikiko Kurushima", Kumiko Toyoda4 "The University of Shiga Prefecture, "Osaka
名称未設定-1
Study on Clinical Factors Affecting the Fungal Culture Test - Relevance of Dry Mouth - Yoshiko YAMAMURA, Yukihiro MOMOTA, Hideyuki TAKANO, Koichi KANI, Katsumi MOTEGI, Fumihiro MATSUMOTO, Masayuki AZUMA
０７０１０７３‐立命‐社会システム１５号／１５‐９－招待－横井
E-mailxiangzhijp@yahoo.co.jp p p Understanding of Asia by Students of Commercial College under the Old System ACaseStudyofTaihoku Commercial College Kaori Yokoi Abstract Using the Taihoku
Web Stamps 96 KJ Stamps Web Vol 8, No 1, 2004
The Journal of the Japan Academy of Nursing Administration and Policies Vol 8, No 1, pp 43 _ 57, 2004 The Literature Review of the Japanese Nurses Job Satisfaction Research Which the Stamps-Ozaki Scale
622 3) 4 6) ) 8) , ,921 40, ) ) 10 11) ) ) ,434 43, ,18
Vol. 15 No. 2 2006 621 626 Λ1 1959 1995 2004 1959 1995 2004 7 1 2) 1 6 3) 11 Λ1 701-0193 288 E-Mail: takao@mw.kawasaki-m.ac.jp 621 622 3) 4 6) 8 15 7) 8) 2 2 1 1959 34 4,697 401 38,921 40,838 500 9) 9
<91E63989F182A482C295618A7789EF8FB4985E8F575F E696E6464>
1 4 1 13 1 4 6 7 2012 7 27 12 50 13 40 1 7 27 13 40 14 30 1 7 28 13 20 14 10 1 Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode Charles L. Bowden
第124回日本医学会シンポジウム
III γ γ γ α γ Molecular Mechanism of Insulin Resistance by Adipocytes TAKASHI KADOWAKI Department of Metabolic Diseases, Graduate School of Medicine, University of Tokyo Key words γ 110 124 TNFα FFA 1,2
サイトメトリー12-1.indd
Cell Growth Inhibition and Apoptosis in Cancer Cells Kazuki Omoteyama, Shoichi Inoue and Alaa-eldin Salah-eldin Department of Environmental Medicine and Informatics, Graduate School of Environmental Earth
VOL. 37 NO. 3 Key words: Drug allergy, LMIT, Penams, Cephems, Cross-reactivity
VOL. 37 NO. 3 Key words: Drug allergy, LMIT, Penams, Cephems, Cross-reactivity CHEMOTHERAPY MAR. 1989 Mble 1. Allcrgy in parients nduced by penams VOL. 37 NO. 3 Table 2. Allergy in patients induced by
表紙ＰＤＦ作成用／ＰＤＦ表紙作成用
2010 Vol.52 No.1 Jpn J School Health Jpn J School Health Aichi University of Education Jpn J School Health Yogo Jpn J School Health Jpn J School Health Educational and Social Survey Research Center,
2
2 3 4 5 6 7 8 9 1 2 3 4 5 10 11 12 1 2 1 2 1 2 13 14 3 17 15 1 2 3 D Usefulness of Tc-99m MIBI SPECT in predicting multidrug resistance gene expression level in non-small cell lung cancer a preliminary
老年医学update2007-08
Geriatric Medicine Update 2007-08 (ISBN978-4-7583-0298-2 C3002) Editor: Journal Publication Committee, The Japan Geriatrics Society 2007. 7. 1 1st ed MEDICAL VIEW, 2007 Printed and Bound in Japan Medical
IPSJ SIG Technical Report Vol.2016-CE-137 No /12/ e β /α α β β / α A judgment method of difficulty of task for a learner using simple
1 2 3 4 5 e β /α α β β / α A judgment method of difficulty of task for a learner using simple electroencephalograph Katsuyuki Umezawa 1 Takashi Ishida 2 Tomohiko Saito 3 Makoto Nakazawa 4 Shigeichi Hirasawa
Core Ethics Vol. a
Core Ethics Vol. CP CP CP Core Ethics Vol. a - CP - - Core Ethics Vol. CP CP CP b CP CP CP e f a c c c c c c CP CP CP d CP ADL Core Ethics Vol. ADL ADL CP CP CP CP CP CP CP,,, d Core Ethics Vol. CP b GHQ
udc-3.dvi
49 UDC 371.279.1 3 4 753 1 2 2 1 2 47 6 2005 11 14 50 No.35, 2006 1 1.1 AO 2003 2004 2005 2005 1 1 2005 1998 1999 2002 12 11 2000 SAT ACT Law School Admission Test LSAT Medical College Admission Test MCAT
The Japanese Journal of Health Psychology, 29(S): (2017)
Journal of Health Psychology Research 2017, Vol. 29, Special issue, 139 149Journal of Health Psychology Research 2016, J-STAGE Vol. Advance 29, Special publication issue, 139 149 date : 5 December, 2016
Parkinson disease : ,
1 2012 7 24 Parkinson disease :10 50 100, 65 10 200 tremor rigidity (pill rolling) Cogwheel rigidity Akinesia Bradykinesia Resting tremor in Parkinson disease Parkinson disease: camptocormia Parkinson's
Perspective-Taking Perspective-Taking.... Vol. No.
Nurses Thinking Process in Understanding Patients Unconscious Denial Tomoko Hayashi Key Words putting oneself in the patient s place, perspective-taking, misunderstand patient s perspective, modifying
CHEMOTHERAPY Fig. 1 Body weight changes of pregnant mice treated orally with AM- 715 Day of sestation
CHEMOTHERAPY CHEMOTHERAPY Fig. 1 Body weight changes of pregnant mice treated orally with AM- 715 Day of sestation CHEMOTHERAPY Table 1 Preliminaly test of AM- 715 1): Mean } SD *: Significant difference
Core Ethics Vol. : - NICU : : - A B C D
Core Ethics Vol.,NMR...... Core Ethics Vol. : - NICU : : - A B C D b: Duff and Campbell A B C: D : a B C b Core Ethics Vol. : -, : C D :.. D.. bd D CD AB CD : Duff C b C B : Core Ethics Vol. C D B A D
STUDIES ON THE RELATION BETWEEN LATE DUMPING SYNDROME AND GLUCAGON RESPONCES TO GLUCOSE Taisuke MATSUI The First Department of Surgery, Nara Medical U
STUDIES ON THE RELATION BETWEEN LATE DUMPING SYNDROME AND GLUCAGON RESPONCES TO GLUCOSE Taisuke MATSUI The First Department of Surgery, Nara Medical University, Kashihara (Director: Prof. H. Nakano) This
untitled
Japan College of Social Work 01 Japan College of Social Work Profile Contents Japan College of Social Work 02 01 Case 02 Case 03 Case 04 Case 05 Case 03 Japan College of Social Work Japan College of Social
FUJII, M. and KOSAKA, M. 2. J J [7] Fig. 1 J Fig. 2: Motivation and Skill improvement Model of J Orchestra Fig. 1: Motivating factors for a
![FUJII, M. and KOSAKA, M. 2. J J [7] Fig. 1 J Fig. 2: Motivation and Skill improvement Model of J Orchestra Fig. 1: Motivating factors for a](/thumbs/91/106106430.jpg "FUJII, M. and KOSAKA, M. 2. J J [7] Fig. 1 J Fig. 2: Motivation and Skill improvement Model of J Orchestra Fig. 1: Motivating factors for a")
/Specially issued Original Paper QOL 1 1 A Proposal of Value Co-creation Model to Promote Elderly People s Community Activities Concerning QOL Improvement Case Studies of Successful Social Activities by
CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study
CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study VOL. 41 S 1 Table 2. Levels (Đg/ml or Đg/g) of S-1006 in serum, bile, and tissue (gallbladder) after oral administration
HPV HPV HPV HPV 7 HPV 8 9 HPV 3 HPV HPV HPV , Becker Ajzen H
3 26 3 Journal of Junshin Gakuen University, HPV Faculty of Health Sciences Vol.3, March 2014 99 HPV Knowledge of and attitudes towards human papillomavirus vaccinations among mothers who have daughters
Japanese Journal of Applied Psychology
Japanese Journal of Applied Psychology 2014, Vol. 40, No. 2, 71 81 1) * Donations and Money-Beliefs, Empathy, and Normative Attitudes About Helping after Great East Japan Earthquake Nobuko WATANABE* Relationships
Title 骨量規定転写因子シュニュリ3の新規標的遺伝子同定と機能解析 Author(s) 石堂, 康弘 Citation Issue Date 2014-06-27 URL http://hdl.handle.net/10232/24125 http://ir.kagoshima-u.ac.jp adult (Schnurri, Shn)3/Hivep3 Runx2 Shn/Hivep Shn3
第５６巻２号／投稿規定・目次・表２・奥付け・背
Feature articlespsychiatric and psychosomatic symptoms in daily clinical practice Originals Mild depressive disorder and panic disorder Kazuomi Inoue Department of Human Development, Naruto University
88 1A AB 1.????,. () 200 A 100,,,.. (,, )..,,,,,,,,,,, [], [ ], [ ],,, [ ],, [ ], [],.. 7
![88 1A AB 1.????,. () 200 A 100,,,.. (,, )..,,,,,,,,,,, [], [ ], [ ],,, [ ],, [ ], [],.. 7](/thumbs/91/104739061.jpg "88 1A AB 1.????,. () 200 A 100,,,.. (,, )..,,,,,,,,,,, [], [ ], [ ],,, [ ],, [ ], [],.. 7")
87 --I 1A09021 1.0 1 2 AB 1-35,,,, () 20 -- 300 A 100 1 2 3,,,,,, 1 4 16 - furukubo-tokunaga.gm@u.tsukuba.ac.jp [] 2 4 23 - [] 3 5 7 kinaba@shimoda.tsukuba.ac.jp 4 5 14 sasakura@kurofune.shimoda.tsukuba.ac.jp
2009年度 東京薬科大学 薬学部 授業計画
2009 2 234 Tokyo University of Pharmacy and Life Sciences since 880 Tokyo University of Pharmacy and Life Sciences Department of Clinical Pharmacy Men's Division Department of Clinical Applied Pharmacy
評論・社会科学 ８５号（よこ）（Ｐ）／３．佐分
well-being well-being well-being well-being QOL well-being satisfaction appraisal 69 well-being 2025 520 http : //www.mhlw.go.jp/ 2000 2004 2005 well-being 1 Walker 1996 ; Picot 1997 2003 2004 Zarit 1980
第５８巻６号／投稿規定・目次・表２・奥付・背
Feature articles 1Why is it that allergic diseases have been increasing? Feature articles 2Space medicine and medicine for the future Review γ ε γ γ γγ α αβ et al et al et al et al et al et al Is nutritional
Isotope News 2017年10月号 No.753
Ishioka Noriko ₁ はじめに RI RI RI RI ₂ 悪性褐色細胞腫と治療の現状 3,000 90 I meta- Iiodo-benzylguanidine I-MIBG 1 ₃ α 線の標的アイソトープ治療 2016 6 223 RaCl2 223 Ra 223 Ra 14 表 1 α 線と β 線の違い -decay (42%) Eα = 5.9 MeV At 7.2 h EC
[2] 1. 2. 2 2. 1, [3] 2. 2 [4] 2. 3 BABOK BABOK(Business Analysis Body of Knowledge) BABOK IIBA(International Institute of Business Analysis) BABOK 7
![[2] 1. 2. 2 2. 1, [3] 2. 2 [4] 2. 3 BABOK BABOK(Business Analysis Body of Knowledge) BABOK IIBA(International Institute of Business Analysis) BABOK 7](/thumbs/40/22240274.jpg "[2] 1. 2. 2 2. 1, [3] 2. 2 [4] 2. 3 BABOK BABOK(Business Analysis Body of Knowledge) BABOK IIBA(International Institute of Business Analysis) BABOK 7")
32 (2015 ) [2] Projects of the short term increase at present. In order to let projects complete without rework and delays, it is important that request for proposals (RFP) are written by reflecting precisely
Appropriate Disaster Preparedness Education in Classrooms According to Students Grade, from Kindergarten through High School Contrivance of an Educati
Appropriate Disaster Preparedness Education in Classrooms According to Students Grade, from Kindergarten through High School Contrivance of an Education of Disaster Preparedness System and Class Practice
ren
51 * 1 1 IT 24 2010 NHK 2010 7.14 1960 1.08 OECD 2 5 1 2011 4 World Association of Sleep Medicine WASM 3 18 World Sleep Day 2011 11 30 no. 22730552 9 3 1 4,000 5,000 1998 4 4.4 3.3 Matsuda, 2011 Cognitive
CHEMOTHERAPY APRIL 1992 Table 2. Concentration of meropenem in human prostatic fluid Table 1. Background of 21 chronic complicated UTI cases * NB + BPH, NB + Kidney tumor, NB + Kidney tuberculosis Table
J Life Sci Res 2014; 12: Osaka Prefecture University Journal of Life Science Research Online ISSN
J Life Sci Res 2014; 12: 15-19 2014 Osaka Prefecture University Journal of Life Science Research Online ISSN 2186-5809 583-8555 3-7-30 577-8567 3-1-1 2014 9 11 2014 10 21 Exposure mild-level LED light
The Journal of the Japan Academy of Nursing Administration and Policies Vol 7, No 2, pp 19 _ 30, 2004 Survey on Counseling Services Performed by Nursi
The Journal of the Japan Academy of Nursing Administration and Policies Vol 7, No 2, pp 19 _ 30, 2004 Survey on Counseling Services Performed by Nursing Professionals for Diabetic Outpatients Not Using
NL09
Information September, 2005 1 2 Japanese Association for Molecular Target Therapy of Cancer News Letter No.9 September, 2005 3 2005 4 Japanese Association for Molecular Target Therapy of Cancer News Letter
<95DB8C9288E397C389C88A E696E6462>
2011 Vol.60 No.2 p.125 129 Development of therapy for amyotrophic lateral sclerosis Masashi AOKI Department of Neurology, Tohoku University School of Medicine, Tohoku University Hospital ALS Center Abstract
Fig. 1 Trends of TB incidence rates for all forms and smear-positive pulmonary TB in Kawasaki City and Japan. Incidence=newly notified cases of all fo
Kekkaku Vol. 79, No. 1: 17-24, 2004 17 (Received 21 Aug. 2003/Accepted 18 Nov. 2003) Fig. 1 Trends of TB incidence rates for all forms and smear-positive pulmonary TB in Kawasaki City and Japan. Incidence=newly
20 Method for Recognizing Expression Considering Fuzzy Based on Optical Flow
20 Method for Recognizing Expression Considering Fuzzy Based on Optical Flow 1115084 2009 3 5 3.,,,.., HCI(Human Computer Interaction),.,,.,,.,.,,..,. i Abstract Method for Recognizing Expression Considering
NL10
Information September, 2006 1 2 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10 September, 2006 3 2006 4 Japanese Association for Molecular Target Therapy of Cancer News Letter
Microsoft PowerPoint UTNP.ppt
Neuropathology Shigeo Murayama 2007.05.21 Department of Neuropathology (Brain Bank) Tokyo Metropolitan Institute of Gerontology Today s Themes A. General consideration Hierarchy of the nervous system Dynamic
02総福研-06_辻.indd
Differences in the Needs of Depending on the Type of Self-Reliance Support Service Facilities for People with Mental Disorders Questionnaire Survey for Users of Facilities in City A, Osaka Prefecture 精神障害者が利用する自立支援サービス事業種別によるニーズの相違について
1 [1, 2, 3, 4, 5, 8, 9, 10, 12, 15] The Boston Public Schools system, BPS (Deferred Acceptance system, DA) (Top Trading Cycles system, TTC) cf. [13] [
![1 [1, 2, 3, 4, 5, 8, 9, 10, 12, 15] The Boston Public Schools system, BPS (Deferred Acceptance system, DA) (Top Trading Cycles system, TTC) cf. [13] [](/thumbs/91/106628466.jpg "1 [1, 2, 3, 4, 5, 8, 9, 10, 12, 15] The Boston Public Schools system, BPS (Deferred Acceptance system, DA) (Top Trading Cycles system, TTC) cf. [13] [")
Vol.2, No.x, April 2015, pp.xx-xx ISSN xxxx-xxxx 2015 4 30 2015 5 25 253-8550 1100 Tel 0467-53-2111( ) Fax 0467-54-3734 http://www.bunkyo.ac.jp/faculty/business/ 1 [1, 2, 3, 4, 5, 8, 9, 10, 12, 15] The
Clinical Study of Effect of Intrathecal Use of Alpha-tocopherol on Chronic Vasospasm Hirotoshi Sano, Motoi Shoda, Youko Kato, Kazuhiro Katada, Youichi
Clinical Study of Effect of Intrathecal Use of Alpha-tocopherol on Chronic Vasospasm Hirotoshi Sano, Motoi Shoda, Youko Kato, Kazuhiro Katada, Youichi Shinomiya and Tetsuo Kanno Department of Neurosurgery,
< > Introduction to Basic Physical Chemistry 1,2 2 [ advanced [ [ [ [ [ KULASIS
< > Introduction to Basic Organic Chemistry 1,2 [ 2 [ 10 11 12 13 14 15 [ [ [ [ KULASIS < > Introduction to Basic Physical Chemistry 1,2 2 [ advanced [ 11 12 14 15 [ [ [ [ KULASIS < > Introduction to Basic
( ) fnirs ( ) An analysis of the brain activity during playing video games: comparing master with not master Shingo Hattahara, 1 Nobuto Fuji
1 1 2 3 4 ( ) fnirs () An analysis of the brain activity during playing video games: comparing master with not master Shingo Hattahara, 1 Nobuto Fujii, 1 Shinpei Nagae, 2 Koji Kazai 3 and Haruhiro Katayose
201/扉
Mohammad Reza SARKAR ARANI Associate Professor, Allameh Tabatabai University Visiting Research Scholar, International Research Center for Japanese Studies 200718 Mohammad Reza SARKAR ARANI Visiting Research
A pp CALL College Life CD-ROM Development of CD-ROM English Teaching Materials, College Life Series, for Improving English Communica
A CALL College Life CD-ROM Development of CD-ROM English Teaching Materials, College Life Series, for Improving English Communicative Skills of Japanese College Students The purpose of the present study
Title 外傷性脊髄損傷患者の泌尿器科学的研究第 3 報 : 上部尿路のレ線学的研究並びに腎機能について Author(s) 伊藤, 順勉 Citation 泌尿器科紀要 (1965), 11(4): Issue Date URL
Title 外傷性脊髄損傷患者の泌尿器科学的研究第 3 報 : 上部尿路のレ線学的研究並びに腎機能について Author(s) 伊藤, 順勉 Citation 泌尿器科紀要 (1965), 11(4): 278-291 Issue Date 1965-04 URL http://hdl.handle.net/2433/112732 Right Type Departmental Bulletin Paper
08医療情報学22_1_水流final.PDF
22 (1), 702002: 59 59- The Problem of Nursing Common Language for the Information Sharing in Clinical Practice The fact-finding in regard to the correspondence between name and content of nursing action
VOL.39 S-3
VOL.39 S-3 CHEMOTHERAPY SEPT.1991 Table 1. Background of characteristics and allocation of 5 healthy male volunteers in a multiple-dose study on panipenem/betamipron Day 1 Fig. 1. Schedule of multiple-dose
RTM RTM Risk terrain terrain RTM RTM 48
Risk Terrain Model I Risk Terrain Model RTM,,, 47 RTM RTM Risk terrain terrain RTM RTM 48 II, RTM CSV,,, RTM Caplan and Kennedy RTM Risk Terrain Modeling Diagnostics RTMDx RTMDx RTMDx III 49 - SNS 50 0
..
A general framework of interventional study in cognitive rehabilitation for the elderly. YOSHIDA Hajime, OOKAWA Ichiro and TUCHIDA Noriaki The present article describes the general framework of our interventional
(2009) 1... / 1 ( ) / 1 ( ) / 1 ( ), 2 ( )
212009................................................ 2............................................ 115 (2009) 1... / 1 ( )........................................... 4 2... / 1 ( )......................................